ID: ALA541803

Max Phase: Preclinical

Molecular Formula: C9H10Cl2FN

Molecular Weight: 185.63

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cl.NC/C(=C/F)c1ccc(Cl)cc1

Standard InChI:  InChI=1S/C9H9ClFN.ClH/c10-9-3-1-7(2-4-9)8(5-11)6-12;/h1-5H,6,12H2;1H/b8-5-;

Standard InChI Key:  WYPZNQXAHYDNNA-HGKIGUAWSA-N

Associated Targets(non-human)

Monoamine oxidase 439 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 185.63Molecular Weight (Monoisotopic): 185.0408AlogP: 2.61#Rotatable Bonds: 2
Polar Surface Area: 26.02Molecular Species: BASEHBA: 1HBD: 1
#RO5 Violations: 0HBA (Lipinski): 1HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 9.09CX LogP: 2.08CX LogD: 0.40
Aromatic Rings: 1Heavy Atoms: 12QED Weighted: 0.75Np Likeness Score: -0.80

References

1. McDonald IA, Lacoste JM, Bey P, Palfreyman MG, Zreika M..  (1985)  Enzyme-activated irreversible inhibitors of monoamine oxidase: phenylallylamine structure-activity relationships.,  28  (2): [PMID:3968682] [10.1021/jm00380a007]

Source